Flipping the Script: Multilevel Mechanisms Linking Methamphetamine Use and HIV | Adam Carrico, Ph.D., A.B.P.P. (5/20/26)

Increasing NAAG Restores Cognitive Deficit in a Murine Model of HIV | Mei Huang, M.D., Ph.D.; Targeting Gender-Specific Gut Microbiota Improves Social and Cognitive Impairments in EcoHIV-Infected Mice | Yannan Li, M.D., Ph.D. (4/29/26)

Evidence for Cortical GABA Stabilization in Cognitively Intact Oldest-Old Adults | Eric Porges, Ph.D. (4/22/26)

Persistence of HIV in CD4+ T cells: Insights from Clonality | Annukka (Annie) Antar, M.D., Ph.D. (4/15/26)

High-Resolution Pan-viral Antibody Profiling and Brain Health in People with HIV | Patricia “Katie” Riggs, D.O. (4/1/26)

Neurophysiological Markers of Elevated Inflammation and Cognitive Impairment in People with HIV | Tony Wilson, Ph.D. (3/25/26)

Neuroimaging of Lyme Disease | Cherie Marvel, Ph.D. (3/18/26)

EphB2-ephrin-B1 Signaling in Microglia and Implications for NeuroHIV | Marcus Kaul, Ph.D. (3/4/26)

Aging, Microglial Glutaminase, and Neurodegenerative Disorders | Jialin C. Zheng, M.D. (2/18/26)

HIV, Cannabis use, and Macrophage Phenotype | Jerel Adam Fields, Ph.D. (2/4/26)

Redefining HIV Persistence: The Role of Monocytes and Macrophages as a Latent Reservoir | Rebecca Veenhuis, Ph.D. (1/28/26)

B Cells at the Blood–Brain Interface: A Legacy of Immune Dysregulation in Treated HIV Infection | Paraskevas (Paris) Filippidis, M.D. (1/21/26)

Does Executive Functioning Training Improve Cognitive Inconsistency and Dispersion in Middle-aged and Older Adults with HIV? | David E. Vance, Ph.D., MGS, FAAN (12/17/25)

Adenosine, Guardian of the Brain: Possible Role in Protecting from HIV Neuropathogenesis | Yoelvis Garcia-Mesa, Ph.D. (12/3/25)

The Intersection of HIV-1 and Extracellular Vesicle Research | Anastasia Williams and Sebastian Molnar (11/12/25)

Leveraging Wearable Technology for Disability Monitoring in People with Neurological Conditions | Kate Fitzgerald (10/29/25)

EcoHIV Infection Facilitates Alzheimer's Disease progression in Mouse Models | Boe-hyun Kim, Ph.D. (10/22/25)

Systems-Level Vulnerabilities in Opioid Use Disorder: Psychosocial, Cognitive, and Neural Correlates | Paul Regier, Ph.D. (10/15/25)

Biological aging, brain imaging and cognitive impairment in persons with HIV | Kalen Petersen, Ph.D. (10/1/25)

Mitochondrial DNA copy number and cognitive impairments among people with and without HIV | Jing Sun, M.D., M.P.H., Ph.D. (9/24/25)

The Impact of Methamphetamine on Macrophages: Contributions to HIV Neuropathogenesis | Jessica Weiselberg (5/21/25)

Risk of Stroke in Diabetes and HIV Infection: New Therapeutic Targets and Treatment Strategies | Tauheed Ishrat, Ph.D. (5/14/25)

Prevalence and Clinical Significance of CSF Alzheimer's Disease Biomarkers | Erin Sundermann, Ph.D. and Lilly Ham (4/30/25)

Can HIV-1 infection affect the onset and progression of Alzheimer’s disease? | Howard Gendelman, M.D. (4/23/25)

HIV Antiretroviral Drugs Trigger Stress Granule Formation in Differentiating Oligodendrocytes | Eliana Von Krusenstiern (4/16/25)

Novel drug delivery modality to suppress HIV neuropathogenesis | Santosh Kumar, Ph.D. (4/2/25)

Antiretroviral Drugs Differentially Affect Autophagy in Primary Human Astrocytes | Laura Cheney, M.D., Ph.D. (3/19/25)

Beyond the Virus: How ART and Non-ART Drugs Shape Neuropsychiatric Health in people with HIV | Yanxun Xu, Ph.D. and Eero Korpela (3/5/25)

The Last Gift Program: Lessons learned from altruistic participants enrolled in HIV Cure research | Sara Gianella Weibel, M.D. (2/26/25)

Neuroinflammatory Brain Injury in HIV Infection with cART | Marcus Kaul, Ph.D. (2/12/25)

Clinical Trials of Therapy for Brain Health Disorders in Persons with HIV | Scott Letendre, M.D. (2/5/25) 

Understanding Psychosocial and Behavioral Constructs Related to PrEP Interest Among Trans-Masculine People Assigned Female at Birth | Ari Gzesh, MSW, Ph.D. Candidate (1/27/25)

Harnessing Public Multi-omics data to Discover Shared Mechanisms in Neuroinflammation | Carlo Colantuoni, Ph.D. (1/15/25)

Drug Analysis One-Stop Shop: A comprehensive spectra library for drug and metabolites developed with public metabolomics data | Nina Zhao, Ph.D. (1/8/25)

Leveraging Redox Dysregulation to Target Latent HIV Infection| Luca Shytaj, Ph.D. (12/18/24)

Joint Effects of Methamphetamine and HIV on Brain Connectivity | Judith Lobo Ph.D. (12/11/24)

Uncovering a Novel Molecular Therapeutic Target for HIV-Associated Neurocognitive Impairment | Reina Bendayan, Pharm.D., FAAPS, FCSPS, FCAHS (11/20/2024)

The Blood Brain Barrier Demonstrates Capability to Influence Heterogenous Tenofovir and Emtricitabine Metabolism and Transport in the Brain | Hannah Wilkins, M.S., Ph.D. Candidate (11/6/2024)

Giving HAND a Helping Hand: A Role for Neuroimaging | Beau Ances, M.D., Ph.D. (10/23/2024)

Brain Macrophages and Amyloid: 35 years of NeuroHIV Research | Cristian Achim, M.D., Ph.D. (10/16/2024)

Cumulative Burden of Depression and Domain-Specific Cognitive Impairment in the Women's Interagency HIV Study: A Marginal Structural Model Approach | César Higgins Tejera, Ph.D. (9/25/2024)

Suicide Risk Reduction Among People with HIV | Lily Brown, Ph.D. (11/8/23)

miRNA Export, Transport and Uptake via Extracellular Vesicles in Mammalian Cells | Suvendra Bhattacharyya, Ph.D. (11/1/23)

Brain N-acetyl-Aspartyl-Glutamate (NAAG) is Positively Associated with Cognitive Function | Robyn Wiseman, Ph.D. Candidate; Tryptophan-Kynurenine Pathway Activation and Daytime Disruption in Women with HIV | Eran Shorer, M.D. (10/25/23)

October 18, 2023: "Acidic Nanoparticles Prevent HIV Pre-exposure Prophylaxis (PrEP) Inhibition of Oligodendrocyte Maturation" Caela Long, PhD Candidate

October 11, 2023: "Measuring Routine and Behavioral Variability Through Smartphone-based Digital Phenotyping" Ian Barnett, PhD

September 27, 2023: "Proviral Location Affects Virus Production and Immune Recognition of HIV-1–infected T cell Clones" Francesco Simonetti, MD, PhD

April 5, 2023: "Dolutegravir inhibits oligodendrocyte differentiation through activation of the integrated stress response" Marisa Jeffries, PhD and “What have we learnt from the RV254 Thai acute HIV cohort” Philip Chan, PhD

March 22, 2023: "Osteopontin promotes cardiac fibrosis in HIV infection" Jake Robinson

March 8, 2023: "Broadly neutralizing anti-HIV antibodies (bNAb) and the CNS" Lucio Gama, PhD

March 1, 2023: "Human microglia phenotypes in the brain associated with HIV infection" Johannes Schlachetzki, MD

February 8, 2023: “Neurologic post-acute sequelae of COVID-19 preliminary findings and directions for future research” Lindsay McAlpine, MD; and "Single Copy HIV and Neurodegeneration, Oxidative Stress, and Neuroinflammation" Albert Anderson, MD

February 1, 2023: "Why do white matter dysfunction and myelin loss persist in HIV+ individuals despite effective antiretroviral therapy?" Judith Grinspan, PhD

January 18, 2023: "Establishing iPSC derived models to study HIV latency and microglia phenotypes" Sheetal Sreeram

January 11, 2023: “Multimodal MRI evidence of frontostriatal alterations in HIV and aging” Shiva Hassanzadeh-Behbahani, PhD; and “Cerebrospinal fluid virome in ART-treated adult people living with HIV” Mattia Trunfio, PhD Candidate

Progressive Neurocognitive Impairments and Neuronal Injury Resulting From Chronic HIV-1 Viral Protein Exposure

The Self-Serving Side of Astrocytes: It’s All About ME!

Choices in HIV Pre-Exposure Prophylaxis: Today, Tomorrow, and Over-the-Horizon

Mitochondrial Alterations in HIV- and ART-Associated Neurotoxicity

Lysosomal De-acidification by the Antiretroviral Bictegravir Inhibits Oligodendrocyte Maturation

Lentiviral infections persist in brain despite effective antiretroviral therapy and neuroimmune activation